-
Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones
Steven H. Zeisel
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
(2012)
733 :34
-
Combinatorial biomarker expression in breast cancer
Emad A. Rakha, Jorge S. Reis-Filho, and Ian O. Ellis
Breast Cancer Research and Treatment
(2010)
120 :293
-
Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating
rapid non-genomic effects
María Cecilia Bottino, Juan Pablo Cerliani, Paola Rojas, Sebastián Giulianelli, Rocío Soldati, Carolina Mondillo, María Alicia
Gorostiaga, Omar P. Pignataro, Juan Carlos Calvo, J. Silvio Gutkind, Panomwat Amornphimoltham, Alfredo A. Molinolo, Isabel
A. Lüthy, and Claudia Lanari
Breast Cancer Research and Treatment
(2011)
126 :621
-
Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Rocío Soldati, Victoria Wargon, Juan Pablo Cerliani, Sebastián Giulianelli, Silvia Inés Vanzulli, María Alicia Gorostiaga,
Julieta Bolado, Pablo do Campo, Alfredo Molinolo, Günter Vollmer, and Claudia Lanari
Breast Cancer Research and Treatment
(2010)
123 :709
-
Action of hexachlorobenzene on tumor growth and metastasis in different experimental models
Carolina Andrea Pontillo, Paola Rojas, Florencia Chiappini, Gonzalo Sequeira, Claudia Cocca, Máximo Crocci, Lucas Colombo,
Claudia Lanari, Diana Kleiman de Pisarev, and Andrea Randi
Toxicology and Applied Pharmacology
(2013)
268 :331
-
Progesterone regulation of stem and progenitor cells in normal and malignant breast
Sunshine Daddario Axlund and Carol A. Sartorius
Molecular and Cellular Endocrinology
(2012)
357 :71
-
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with
different hormonal requirements
Sebastián Giulianelli, Jason I. Herschkowitz, Vyomesh Patel, Caroline A. Lamb, J. Silvio Gutkind, Alfredo Molinolo, Charles
M. Perou, and Claudia Lanari
Breast Cancer Research and Treatment
(2011)
129 :49
-
Antiprogestins in breast cancer treatment: are we ready?
C. Lanari, V. Wargon, P. Rojas, and A. A. Molinolo
Endocrine Related Cancer
(2012)
19 :R35
-
Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation
C Pérez Piñero, A Bruzzone, MG Sarappa, LF Castillo, and IA Lüthy
British Journal of Pharmacology
(2012)
166 :721
-
Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer
Juan P. Cerliani, Silvia I. Vanzulli, Cecilia Pérez Piñero, María C. Bottino, Ana Sahores, Myriam Nuñez, Romina Varchetta,
Rubén Martins, Eduardo Zeitlin, Stephen M. Hewitt, Alfredo A. Molinolo, Claudia Lanari, and Caroline A. Lamb
Breast Cancer Research and Treatment
(2012)
133 :997
-
Progesterone receptor action: defining a role in breast cancer
Andrea R Daniel, Christy R Hagan, and Carol A Lange
Expert Review of Endocrinology & Metabolism
(2011)
6 :359
-
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
Martin A Rivas, Leandro Venturutti, Yi-Wen Huang, Roxana Schillaci, Tim Huang, and Patricia V Elizalde
Breast Cancer Research
(2012)
14 :R77
-
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
Victoria Wargon, Sandra V. Fernandez, Mercedes Goin, Sebastián Giulianelli, Jose Russo, and Claudia Lanari
Breast Cancer Research and Treatment
(2011)
126 :319
-
PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast
cancer
M. Riggio, M. L. Polo, M. Blaustein, A. Colman-Lerner, I. Luthy, C. Lanari, and V. Novaro
Carcinogenesis
(2012)
33 :509
-
Pregnancy-Induced Changes in Breast Cancer Risk
Irma H. Russo and Jose Russo
Journal of Mammary Gland Biology and Neoplasia
(2011)
16 :221
-
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
Roxana Schillaci, Pablo Guzmán, Florencia Cayrol, Wendy Beguelin, María C Díaz Flaqué, Cecilia J Proietti, Viviana Pineda,
Jorge Palazzi, Isabel Frahm, Eduardo H Charreau, Esteban Maronna, Juan C Roa, and Patricia V Elizalde
BMC Cancer
(2012)
12 :74
-
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer
growth
M. Tkach, C. Rosemblit, M. A. Rivas, C. J. Proietti, M. C. Diaz Flaque, M. F. Mercogliano, W. Beguelin, E. Maronna, P. Guzman,
F. G. Gercovich, E. G. Deza, P. V. Elizalde, and R. Schillaci
Endocrine Related Cancer
(2013)
20 :197
-
Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells
Mei Li, Dan Zhao, Gui Ma, Baotong Zhang, Xiaoying Fu, Zhengmao Zhu, Liya Fu, Xiaodong Sun, and Jin-Tang Dong
Biochemical and Biophysical Research Communications
(2013)
430 :358
-
Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast
cancer cells
Akash Gupta, Rajeshwari Mehta, Fatouma Alimirah, Xinjian Peng, Genoveva Murillo, Ronald Wiehle, and Rajendra G. Mehta
The Journal of Steroid Biochemistry and Molecular Biology
(2013)
133 :30
